Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial

Author： Ozturk B.   Egehan I.   Atavci S.   Kitapci M.  

Publisher： Elsevier

ISSN： 0360-3016

Source： International Journal of Radiation Oncology*Biology*Physics, Vol.58, Iss.1, 2004-01, pp. : 213-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer

By Misirlioglu Cem   Demirkasimoglu Taciser   Kucukplakci Bulent   Sanri Ergun   Altundag Kadri  

Medical Oncology, Vol. 24, Iss. 3, 2007-09 ,pp. : 308-311

Humana Press, Inc

Access to resources Recommend Favorite

L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 33-39

Spandidos Publications

Access to resources Recommend Favorite

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

By Hu Zhihuang   Cheng Ying   Zhang Hongyu   Zhou Caicun   Han Baohui   Zhang Yiping   Huang Cheng   Chang Jianhua   Song Xiangqun   Liang Jun   Liang Houjie   Bai Chunxue   Yu Shiying   Chen Jia   Wang Jie   Pan Hongming   Chitkara Denesh   Hille Darcy   Zhang Li  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

By Clemons Mark   Joy Anil   Abdulnabi Radhi   Kotliar Mauricio   Lynch Jodi   Jordaan Johan   Iscoe Neill   Gelmon Karen  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

By Miles David   Baselga José   Amadori Dino   Sunpaweravong Patrapim   Semiglazov Vladimir   Knott Adam   Clark Emma   Ross Graham   Swain Sandra  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 89-99

Springer Publishing Company

Access to resources Recommend Favorite